Capital Advisors Wealth Management »

Esperion Therapeutics shares owned by Capital Advisors Wealth Management

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Capital Advisors Wealth Management from 13F filings

Historical chart of Capital Advisors Wealth Management investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Capital Advisors Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Capital Advisors Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $113k 43k 2.65
2025-06-30 $42k 43k 0.98
2025-03-31 $61k 43k 1.44
2024-12-31 $77k 35k 2.20
2024-09-30 $53k 32k 1.65
2024-06-30 $60k 27k 2.22
2024-03-31 $58k 22k 2.68

More positions owned by Capital Advisors Wealth Management

Schwab Strategic Tr Fundamental Intl (FNDF)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Vanguard World Inf Tech Etf (VGT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
J P Morgan Exchange Traded F Income Etf (JPIE)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Bd Index Fds Long Term Bond (BLV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard Whitehall Fds Intl High Etf (VYMI)

View all positions for Capital Advisors Wealth Management

Top funds holding Esperion Therapeutics

BlackRock
Vanguard Group
Two Seas Capital
Daniel D. Thurber
PenderFund Capital Management
Geode Capital Management
State Street Corporation
Nuveen
AIGH Capital Management
Marshall Wace
Royce & Associates
Two Sigma Investments
Jane Street
Citadel Advisors
Two Sigma Advisers

View all funds holding Esperion Therapeutics